PCA Regenerative Medicine Advisory Board

Lee Rubin, PhD

Harvard University; Harvard Stem Cell Institute

Lee Rubin, Ph.D., is Professor of Stem Cell and Regenerative Biology at Harvard University and Director of Translational Medicine and executive committee member at the Harvard Stem Cell Institute. He received his Ph.D. in Neuroscience from The Rockefeller University and completed postdoctoral fellowships in Pharmacology from Harvard Medical School and in Neurobiology from Stanford University School of Medicine. Dr. Rubin has broad experience in both academia and industry, particularly in the realms of cell-based assays and drug discovery. Prior to Harvard, he was Chief Scientific Officer of Curis, Inc., a Cambridge-based biotechnology company, where his group identified the first small molecule regulators of the hedgehog signaling pathway. One of these molecules was developed by Genentech/Roche and is now an approved cancer treatment (Erivedge). The Rubin Laboratory focuses on translational, high-throughput research to model disease and develop drugs using stem cells.